Prof dr Mirjana Gotic, MD, PhD - Medical Faculty, University of Belgrade, Clinical Centre of Serbia, Belgrade - Haed of the Polyclynic/Diagnostic Department, Clinic for Hematology CCS

Prof dr Mirjana Gotic

MD, PhD

Medical Faculty, University of Belgrade, Clinical Centre of Serbia, Belgrade

Haed of the Polyclynic/Diagnostic Department, Clinic for Hematology CCS

Belgrade | Yugoslavia

Additional Specialties: Internal Medicine, Hematology

ORCID logohttps://orcid.org/0000-0002-8590-0328

Prof dr Mirjana Gotic, MD, PhD - Medical Faculty, University of Belgrade, Clinical Centre of Serbia, Belgrade - Haed of the Polyclynic/Diagnostic Department, Clinic for Hematology CCS

Prof dr Mirjana Gotic

MD, PhD

Introduction

Primary Affiliation: Medical Faculty, University of Belgrade, Clinical Centre of Serbia, Belgrade - Belgrade , Yugoslavia

Additional Specialties:

Research Interests:

Publications

30Publications

1807Reads

1Profile Views

86PubMed Central Citations

β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study.

Ultrastruct Pathol 2018 Nov-Dec;42(6):498-507. Epub 2018 Dec 24.

a Department of Molecular Oncology , Institute for Medical Research, University of Belgrade , Belgrade , Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01913123.2018.1558323DOI Listing
March 2019
22 Reads
1.133 Impact Factor

IL-6 stimulation of DNA replication is JAK1/2 mediated in cross-talk with hyperactivated ERK1/2 signaling.

Cell Biol Int 2019 Feb 7;43(2):192-206. Epub 2019 Jan 7.

Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbin.11084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347554PMC
February 2019
17 Reads
1.933 Impact Factor

TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.

Cell Oncol (Dordr) 2018 Oct 26;41(5):541-553. Epub 2018 Jun 26.

Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Dr. Subotica 4, Belgrade, 11129, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-018-0392-6DOI Listing
October 2018
22 Reads
3.032 Impact Factor

Recommendations for the diagnosis and treatment of patients with polycythaemia vera.

Eur J Haematol 2018 Jul 30. Epub 2018 Jul 30.

Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13156DOI Listing
July 2018
180 Reads
2.070 Impact Factor

Macrophage migration inhibitory factor is an endogenous regulator of stress-induced extramedullary erythropoiesis.

Histochem Cell Biol 2016 Sep 30;146(3):311-24. Epub 2016 Apr 30.

Department of Experimental Hematology, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00418-016-1442-7DOI Listing
September 2016
41 Reads
1 Citation
3.054 Impact Factor

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms.

Mediators Inflamm 2015 29;2015:453020. Epub 2015 Sep 29.

Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/453020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602333PMC
August 2016
106 Reads
8 Citations
3.240 Impact Factor

[Treatment by bloodletting in the past and present].

Srp Arh Celok Lek 2016 Mar-Apr;144(3-4):240-8

View Article

Download full-text PDF

Source
August 2016
28 Reads
0.170 Impact Factor

Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway.

PLoS One 2015 14;10(8):e0135463. Epub 2015 Aug 14.

Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0135463PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537205PMC
May 2016
49 Reads
4 Citations
3.234 Impact Factor

Predictors of survival and cause of death in patients with essential thrombocythemia.

Eur J Haematol 2015 Nov 25;95(5):461-6. Epub 2015 Mar 25.

Medical Faculty, University of Belgrade, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12517DOI Listing
November 2015
39 Reads
1 Citation
2.070 Impact Factor

Diagnostic challenges during pretreatment long-term follow-up in a patient with FIP1L1-PDGFRA-positive eosinophilia.

Intern Med 2015 15;54(6):637-42. Epub 2015 Jan 15.

Clinic for Hematology, Clinical Center of Serbia, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.54.2258DOI Listing
September 2015
12 Reads
0.970 Impact Factor

The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia.

Med Oncol 2014 Oct 16;31(10):231. Epub 2014 Sep 16.

Clinic for Hematology, Clinical Center of Serbia, Koste Todorovica 2, 11 000, Belgrade, Serbia,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12032-014-0231
Web Search
http://link.springer.com/10.1007/s12032-014-0231-1
Publisher Site
http://dx.doi.org/10.1007/s12032-014-0231-1DOI Listing
October 2014
54 Reads
1 Citation
2.060 Impact Factor

Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosis.

Med Oncol 2014 Mar 6;31(3):869. Epub 2014 Feb 6.

Clinic for Hematology, Clinical Center of Serbia, Koste Todorovica 2, 11 000, Belgrade, Serbia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-014-0869-8DOI Listing
March 2014
30 Reads
11 Citations
2.060 Impact Factor

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial.

Blood 2013 Mar 11;121(10):1720-8. Epub 2013 Jan 11.

Medical University of Vienna, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-07-443770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591796PMC
March 2013
131 Reads
32 Citations
10.452 Impact Factor

[New concept of the treatment in elderly patients with multiple myeloma].

Srp Arh Celok Lek 2011 Dec;139 Suppl 2:110-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2298/sarh11s2110bDOI Listing
December 2011
37 Reads
0.170 Impact Factor

Simultaneous presentation of hairy cell leukemia and metastatic signet ring carcinoma of the stomach diagnosed by bone marrow biopsy.

Appl Immunohistochem Mol Morphol 2011 May;19(3):279-82

Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e3181f7b30fDOI Listing
May 2011
68 Reads
1 Citation

T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.

Med Oncol 2010 Jun 21;27(2):286-90. Epub 2009 Mar 21.

Institute of Hematology, Clinical Center Serbia, Koste Todorovica 2 Street, 11 000 Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-009-9206-zDOI Listing
June 2010
49 Reads
3 Citations
2.060 Impact Factor

t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia.

Int J Hematol 2009 May 26;89(4):508-512. Epub 2009 Mar 26.

Clinical Center Serbia, Institute of Hematology, Koste Todorovića 2 Street, 11000, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-009-0275-8DOI Listing
May 2009
48 Reads
1.680 Impact Factor

Spinal epidural granulocytic sarcoma in non-leukemic patient.

Int J Hematol 2009 Jan 26;89(1):95-97. Epub 2008 Dec 26.

Institute of Hematology, Clinical Center of Serbia, Koste Todorovica 2, 11000, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12185-008-0227-8
Publisher Site
http://dx.doi.org/10.1007/s12185-008-0227-8DOI Listing
January 2009
19 Reads
8 Citations
1.680 Impact Factor

Pattern of trisomy 1q in hematological malignancies: a single institution experience.

Cancer Genet Cytogenet 2008 Oct;186(1):12-8

Institute of Hematology, Clinical Center of Serbia, 2 Koste Todorovicaa, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546080800286
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2008.05.003DOI Listing
October 2008
84 Reads
4 Citations

Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.

Cancer Genet Cytogenet 2007 Feb;173(1):57-62

Institute of Hematology, Clinical Center of Serbia, Koste Todorovića 2, 11000 Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546080600650
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2006.09.021DOI Listing
February 2007
37 Reads
1 Citation

A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro).

Ann Hematol 2006 Aug 12;85(8):514-9. Epub 2006 May 12.

Institute of Epidemiology, School of Medicine, University of Belgrade, Visegradska 26A, Belgrade 11000, Serbia Montenegro.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-006-0128-y
Publisher Site
http://dx.doi.org/10.1007/s00277-006-0128-yDOI Listing
August 2006
59 Reads
7 Citations
2.634 Impact Factor

A novel t(2;17) in transformation of essential thrombocythemia to acute myelocytic leukemia.

Cancer Genet Cytogenet 2004 Jan;148(1):77-9

Institute of Hematology, Clinical Center of Serbia, Koste Todorovica 2 Street, Belgrade, Serbia, Yugoslavia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(03)00215-2DOI Listing
January 2004
76 Reads

Top co-authors

Mirjana Gotic
Mirjana Gotic

Medical Faculty, University of Belgrade, Clinical Centre of Serbia, Belgrade

15
Vladan P Cokic
Vladan P Cokic

Institute for Medical Research

6
Andrija Bogdanovic
Andrija Bogdanovic

Clinical Center of Serbia

4
Maja Perunicic-Jovanovic
Maja Perunicic-Jovanovic

Clinic for Hematology

4
Natasa Milic
Natasa Milic

Clinical Center of Serbia

4